All News
|
Research Feature
Activating a protein in red blood cells may improve anemia and alleviate acute episodes of severe pain for people living with sickle cell disease Swee Lay Thein, M.B., D.Sc., a senior investigator and chief of NHLBI’s Sickle Cell Branch, shares insight into a decade-long research journey that may lead to new ways to help people living with sickle...
Showing 10 out of 98 results
|
NHLBI in the Press
A study with more than 100,000 adults found that breakthrough COVID-19 infections occurred among 4.4% of people living with HIV compared to 3.5% of people living without HIV. These findings may support future COVID-19 vaccine guidance for adults living with HIV.
|
NHLBI in the Press
Thirty patients who received lung transplants for a COVID-19-related complication survived and were living about a year after the operation, according to research published in JAMA.
|
NHLBI in the Press
Nearly 90% of COVID-19 patients who qualified for but did not receive ECMO (extracorporeal membrane oxygenation) due to a shortage of devices during the pandemic died in the hospital.
|
NHLBI in the Press
New research about the stickiness of blood vessels following an immune response some people may have to COVID-19 may help explain why the virus can affect so many organs, including the heart, lungs, and brain.
|
Media Availability
WHAT: After studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers, including those who work at the National Institutes of Health, identified “rogue antibodies” that correlate with severe illness and may help explain mechanisms associated with severe blood clotting. The researchers found circulating...
|
Research Feature
It’s a fact few can dispute: The COVID-19 pandemic has been devastating on Americans. It has caused high rates of death and illness, disrupted nearly every aspect of daily life, and been linked to increased heart disease, lung disease, obesity, and sleep problems. Now, NHLBI-funded researchers say the virus and related stress can also be blamed for...
|
Research Feature
NIH research continues to evaluate how blood thinners and anti-inflammatory medications may strengthen recovery at different points in the life of the virus W. Keith Hoots, M.D., director of the Division of Blood Disorders and Resources (DBDR) at the National Heart, Lung, and Blood Institute (NHLBI), shares insight into how treatments that break up...
|
Research Feature
Severe blood clotting in patients has sent researchers in search of answers to optimize treatment and recovery As the virus that causes COVID-19 invades cells and replicates its code for infection, the body’s immune response fights back. However, for some people this can lead to extreme blood clotting – which can increase the risk for heart attack...
|
NHLBI in the Press
A clinical research trial with hundreds of participants was stopped early after it became apparent that neither aspirin nor an anti-clotting medication strengthened recovery among patients with COVID-19 who did not require hospitalization.
|
NHLBI in the Press
After reviewing the electronic health records of 72,147 patients with COVID-19, Cleveland Clinic researchers found those who had previously used a steroid-based nasal spray prior to infection were less likely to be hospitalized, receive intensive care, or die prematurely.